Minjia Tan

机构：Guangzhou University of Chinese Medicine, Nanjing University of Chinese Medicine, Zunyi Medical University, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, Drug Discovery Laboratory (Norway), Huashan Hospital, Shanghai Center for Brain Science and Brain-Inspired Technology, University of Chinese Academy of Sciences, State Key Laboratory of Drug Research, Southern Medical University, Academia Sinica · ORCID：0000-0002-6784-9653

发表论文 283 篇 · 总被引 18612 次 · h-index 55

代表论文

• Biocatalytic- and Chemoproteomic-Guided Discovery of a PHGDH Inhibitor from Chemoenzymatic-Promoted DNA-Encoded Libraries Selection Platform (2025 · Journal of the American Chemical Society · 被引 10)
• In-depth analysis of data characteristics and comparative evaluation of dda and dia accuracy in label-free quantitative proteomics of biological samples (2025 · Clinical Proteomics · 被引 8)
• CBX4 acetoacetylation as an inhibitory mechanism of HIF-1α activity (2025 · Cell chemical biology · 被引 5)
• Proteogenomic Characterization Reveals Metabolic Vulnerabilities and Aberrant Phosphorylation in Colorectal Metastasis to Liver (2025 · Advanced Science · 被引 3)
• Recent progress in histone post-translational modifications as regulators of metabolic diseases: A review (2025 · International Journal of Biological Macromolecules · 被引 3)
• Multiplexed Photo-Cross-Linking Reveals Comprehensive Midnolin Interactome: Insights into Ubiquitin-Independent Degradation and Functional Diversity (2026 · Journal of the American Chemical Society · 被引 2)